Prevention of HBV reactivation in patients treated with biologic agents.

about

Management of psoriasis patients with hepatitis B or hepatitis C virus infection

P2860

Q28078157-94FF3277-E8E0-43FE-9BFC-CDB7957FC0E5

P2860

Prevention of HBV reactivation in patients treated with biologic agents.

Item

http://www.wikidata.org/entity/Q40830395

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Prevention of HBV reactivation in patients treated with biologic agents.

@en

type

Item

label

Prevention of HBV reactivation in patients treated with biologic agents.

@en

prefLabel

Prevention of HBV reactivation in patients treated with biologic agents.

@en

P1476

Prevention of HBV reactivation in patients treated with biologic agents

@en

P2093

Konstantinos Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendations

Management of patients with hepatitis B who require immunosuppressive therapy

Hepatitis B flares in chronic hepatitis B: pathogenesis, natural course, and management

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

Chronic hepatitis B: update 2009

Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?

Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance.

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.

P304

579-589

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2016.1143773

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dimitrios Vassilopoulos

C Koutsianas

P577

2016-02-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26775683

http://www.w3.org/2001/XMLSchema#string

Prevention of HBV reactivation in patients treated with biologic agents.

about

P2860

P2860

Prevention of HBV reactivation in patients treated with biologic agents.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698